DBV Technologies S.A.
VIASKIN Peanut Patch
peanut allergy
Date
TBD
Advisory committee · Date TBD estimated
What's at stake
An FDA advisory committee reviews VIASKIN Peanut Patch for peanut allergy around Date TBD. The panel's public vote often front-runs the agency's final verdict — and the share price.
Primary source
· SEC 8-K
verified 14h ago
“Maintained active engagement with allergy, immunology, and patient advocacy communities through participation in leading scientific and medical congresses, including American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting”